Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Neuronetics Inc
(NQ:
STIM
)
0.9650
-0.0093 (-0.95%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Neuronetics Inc
< Previous
1
2
3
4
5
6
Next >
Neuronetics Launches Latest Evolution in its TrakStar® Patient Data Management System
February 12, 2024
Advancements provide workflow efficiencies for NeuroStar® TMS providers
From
Neuronetics
Via
GlobeNewswire
NeuroStar TMS Patient Access Expands Through Lucet Health Policy Update
February 06, 2024
Criteria Change Reduces Requirements for Treatment Accessibility
From
Neuronetics
Via
GlobeNewswire
Neuronetics Receives 510(k) Clearance for NeuroSite™ Coil Placement Accessory
December 18, 2023
New accessory for NeuroStar TMS reduces patient setup steps and improves efficiency for providers
From
Neuronetics
Via
GlobeNewswire
NeuroStar TMS Receives Expanded Regulatory Approval in Japan
December 04, 2023
Technological advances reduce time and increase efficiency for MDD treatment
From
Neuronetics
Via
GlobeNewswire
NeuroStar Elevates Depression Treatment with Cutting-Edge Technology Advancements
November 13, 2023
New updates designed to advance practice efficiency and patient outcomes
From
Neuronetics
Via
GlobeNewswire
Neuronetics Announces Continued Momentum from Health Plans for TMS Therapy Coverage
November 09, 2023
Policy Updates from Magellan and Two Additional Payors Increase Access for 3.2 Million Covered Lives
From
Neuronetics
Via
GlobeNewswire
Brain Stimulation Highlights Best Practices for Optimal TMS Treatment Outcomes
October 16, 2023
Findings confirm strong correlation between the number of TMS treatment sessions completed and improvement in MDD
From
Neuronetics
Via
GlobeNewswire
Earnings Scheduled For November 7, 2023
November 07, 2023
Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter.
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
September 21, 2023
During the session on Thursday, 461 stocks hit new 52-week lows.
Via
Benzinga
In Recognition of Suicide Prevention Month, NeuroStar Voices Portal Amplifies Stories of Real People Beating Depression
September 12, 2023
Portal provides resources to raise awareness around mental health and suicide prevention
From
Neuronetics
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Thursday
September 07, 2023
On Thursday, 283 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
August 22, 2023
On Tuesday, 210 companies reached new 52-week lows.
Via
Benzinga
NeuroStar Advanced Therapy Wins 2023 dotCOMM Awards
August 21, 2023
Award Acknowledges Excellence in Digital Marketing Efforts
From
Neuronetics
Via
GlobeNewswire
Neuronetics Revolutionizes Patient Communication and Provider Support Through Its Exclusive TrakStar® Platform
August 14, 2023
New automated features elevate the standard of care for NeuroStar® Advanced Therapy practices
From
Neuronetics
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
August 11, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
August 11, 2023
During the Friday's sesion, 157 stocks hit new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
August 10, 2023
On Thursday, 128 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
August 04, 2023
On Friday, 73 companies reached new 52-week lows.
Via
Benzinga
Neuronetics Announces Expanded TMS Therapy Access Through Aetna® Health Plans
July 19, 2023
Policy Updates Impact Nationwide Commercial Plans for 16.8 Million Covered Lives
From
Neuronetics
Via
GlobeNewswire
Neuronetics' NeuroStar Gets Regulatory Clearance In South Korea
July 17, 2023
Neuronetics, Inc. (NASDAQ: STIM) announced that the Ministry of Food and Drug Safety (MFDS) in South Korea has approved multiple features of NeuroStar TMS (transcranial magnetic stimulation) for
Via
Benzinga
NeuroStar Advanced Therapy Wins 2023 Bulldog PR Award For Partnership With Drew Robinson, Mental Health Advocate and Former MLB Player
July 11, 2023
Award Recognizes Efforts to Raise Awareness Around Non-Drug Depression Treatment
From
Neuronetics
Via
GlobeNewswire
NeuroStar Achieves Milestone Regulatory Clearance in South Korea
July 17, 2023
First International Approval for Expanded Indication and Certification for MT Cap and D-Tect™ Technologies
From
Neuronetics
Via
GlobeNewswire
Neuronetics Receives 510(k) Clearance for OCD MT Cap for NeuroStar Advanced Therapy
June 12, 2023
The Company expands technology for patients with obsessive-compulsive disorder
From
Neuronetics
Via
GlobeNewswire
Neuronetics Announces Increased TMS Access Through BlueCross BlueShield Of Michigan
May 26, 2023
Lower Medication Requirement Helps Depression Patients Obtain Treatment Sooner
From
Neuronetics
Via
GlobeNewswire
New Depression Barometer Survey Shows Patients Are Stopping Treatment Due to Dissatisfaction
May 23, 2023
Lowest satisfaction among medication users, highest for users of non-drug solution TMS Therapy
From
Neuronetics
Via
GlobeNewswire
Neuronetics Wins 2023 Bell Seal for Workplace Mental Health
May 15, 2023
The Company is recognized for its commitment to employees’ well-being
From
Neuronetics
Via
GlobeNewswire
Why PRA Group Shares Are Trading Lower By 44%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
May 09, 2023
Gainers TScan Therapeutics, Inc. (NASDAQ: TCRX) shares gained 118% to $4.68 after the company and Amgen announced collaboration to identify novel targets in Crohn's disease.
Via
Benzinga
Neuronetics Receives MDSAP Certification and CE Mark Certification under New MDR
May 08, 2023
Achievement demonstrates Company’s commitment to rigorous standards for safe and effective products
From
Neuronetics
Via
GlobeNewswire
Earnings Scheduled For May 9, 2023
May 09, 2023
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.17 per share on revenue of $440.16 million.
Via
Benzinga
Neuronetics Showcases New NeuroStar® TMS Findings at Clinical TMS Society Annual Meeting
May 03, 2023
Data highlights the Company’s commitment to advancing TMS and improving patient outcomes
From
Neuronetics
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.